AT
Actinogen Medical Limited
ATGGF · OTC
$0.04 +0.00% (+$0.00)
1M -12.50%
Market Cap $182.2M
P/E Ratio -
Div. Yield -
ROE 85.31%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 8.54x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 16.77%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 85.31%
ROA 52.03%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 3.45x
Int. coverage -60.34x
Debt/Equity 0.22x
Stability
56 /100
Moderate Rev. volatility 105.05%
EPS volatility 11.80%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ATGGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven G. Gourlay
Employees
6
Headquarters
Sydney
Evenimente viitoare
24 FEB.
Earnings
Upcoming earnings report